Noticias

BioAssays funded by CDTI under Europenan EraNet Co-Biotech programme.

BioAssays increases its R+D+i lines with Hombiocat project, focused on the fabrication of biocatalysts for renewable feedstocks exploitation.

BioAssays has been funded by CDTI as national agent of the European Commission for the EraNet Co-Biotech Programme (Horizon 2020) to execute the activities that BioAssays leads and participates together with other 4 European academic groups for the development of biocatalysts for amino acid production from renewable feedstocks.

 

Thanks to this project, BioAssays consolidates its trajectory as R+D+i company in Biotechnology.

Author


Avatar